Pulse Biosciences, Inc. (PLSE) Tops Q3 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/29/2026
- Visa (V) To Cut 7% Of Its Workforce, Totaling About 2,600 Jobs - Bloomberg
- HF Sinclair plans to spin off lubricants unit, close Canadian refinery
- SoFi Technologies (SOFI) Tops Q2 EPS by 1c ; Offers Guidance
- Crude Inventory Fell 7.2 Million Barrels Last Week - EIA
- S&P 500 ends higher as investors await tech earnings
- After-Hours Stock Movers: META, MSFT, CMG, SBUX, CVNA, LRCX, FTNT, QCOM, TDOC
- After-Hours Stock Movers: F, BE, STX, WDC, KLAC, SWKS, NXPI, CSGP, ENPH
- After-Hours Stock Movers: FFIV, CDNS, APLD, RMBS, ESI, SANM
- After-Hours Stock Movers: INTC, AMD, ARM, MXL, EW, DECK
- After-Hours Stock Movers: GOOGL, TSLA, NOW, IBM, TXN, MOH, URI
Pulse Biosciences (PLSE) PT Lowered to $43 at H.C. Wainwright
November 16, 2021 6:38 AM ESTH.C. Wainwright analyst Swayampakula Ramakanth lowered the price target on Pulse Biosciences (NASDAQ: PLSE) to $43.00 (from $46.00) while maintaining a Buy rating.
The analyst commented, "Pulse reported 3Q21 financial results and held a conference call on November 15. During the quarter, while Pulse is... More
